Ionis Pharmaceuticals IONS Other current assets
Other current assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's other current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's other current assets?
- Ionis Pharmaceuticals (IONS) reported other current assets of $306.08M in Q1 2026.
- How has Ionis Pharmaceuticals's other current assets changed year-over-year?
- Ionis Pharmaceuticals's other current assets increased by 37.5% year-over-year, from $222.57M to $306.08M.
- What is the long-term trend for Ionis Pharmaceuticals's other current assets?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's other current assets has grown at a 11.1% compound annual growth rate (CAGR), from $140.16M to $237.09M.